guaifenesin has been researched along with Pneumonia, Viral in 11 studies
Guaifenesin: An expectorant that also has some muscle relaxing action. It is used in many cough preparations.
Pneumonia, Viral: Inflammation of the lung parenchyma that is caused by a viral infection.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The incidence of dyspnea, poor spirits, mixed infections, and other symptoms in the BMP group was higher than in the control group." | 1.72 | Predictive Value of Adenoviral Load for Bronchial Mucus Plugs Formation in Children with Adenovirus Pneumonia. ( Chen, M; Chen, Y; Deng, L; Ding, X; Huang, H; Li, Y; Lin, L; Liu, S; Peng, L; Wei, S; Xie, T; Yang, Z; Zhong, L, 2022) |
| "To estimate the incidence of influenza-virus-associated severe pneumonia among Salvadorian children aged < 5 years." | 1.38 | Estimated incidence of influenza-virus-associated severe pneumonia in children in El Salvador, 2008-2010. ( Armero, J; Azziz-Baumgartner, E; Blanco, N; Bonilla, L; Bresee, J; Chacón, R; Clara, W; de Lozano, C; Jara, J; Klimov, A; Linares-Perez, N; Minaya, P; Rodriguez, D; Widdowson, MA; Xu, X, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 8 (72.73) | 2.80 |
| Authors | Studies |
|---|---|
| Peng, L | 1 |
| Liu, S | 1 |
| Xie, T | 1 |
| Li, Y | 1 |
| Yang, Z | 1 |
| Chen, Y | 1 |
| Deng, L | 1 |
| Huang, H | 1 |
| Ding, X | 1 |
| Chen, M | 1 |
| Lin, L | 1 |
| Wei, S | 1 |
| Zhong, L | 1 |
| Huang, JJ | 1 |
| Yuan, L | 1 |
| Zhuo, ZQ | 1 |
| Li, MZ | 1 |
| Wu, XD | 1 |
| Esam, Z | 2 |
| Matson, MJ | 1 |
| Yinda, CK | 1 |
| Seifert, SN | 1 |
| Bushmaker, T | 1 |
| Fischer, RJ | 1 |
| van Doremalen, N | 1 |
| Lloyd-Smith, JO | 1 |
| Munster, VJ | 1 |
| Khashkhosha, HK | 1 |
| Elhadi, M | 1 |
| Pujadas, E | 1 |
| Chaudhry, F | 1 |
| McBride, R | 1 |
| Richter, F | 1 |
| Zhao, S | 1 |
| Wajnberg, A | 1 |
| Nadkarni, G | 1 |
| Glicksberg, BS | 1 |
| Houldsworth, J | 1 |
| Cordon-Cardo, C | 1 |
| Poon, WCK | 1 |
| Brown, AT | 1 |
| Direito, SOL | 1 |
| Hodgson, DJM | 1 |
| Le Nagard, L | 1 |
| Lips, A | 1 |
| MacPhee, CE | 1 |
| Marenduzzo, D | 1 |
| Royer, JR | 1 |
| Silva, AF | 1 |
| Thijssen, JHJ | 1 |
| Titmuss, S | 1 |
| Clara, W | 1 |
| Armero, J | 1 |
| Rodriguez, D | 1 |
| de Lozano, C | 1 |
| Bonilla, L | 1 |
| Minaya, P | 1 |
| Chacón, R | 1 |
| Jara, J | 1 |
| Blanco, N | 1 |
| Widdowson, MA | 1 |
| Bresee, J | 1 |
| Xu, X | 1 |
| Klimov, A | 1 |
| Azziz-Baumgartner, E | 1 |
| Linares-Perez, N | 1 |
| Hamelin, ME | 1 |
| Prince, GA | 1 |
| Gomez, AM | 1 |
| Kinkead, R | 1 |
| Boivin, G | 1 |
| Murphy, S | 1 |
| Florman, AL | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Nasopharyngeal Wash With Normal Saline on SARS-CoV2 Viral Load: A Randomized Controlled Trial[NCT05525832] | 50 participants (Actual) | Interventional | 2021-06-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for guaifenesin and Pneumonia, Viral
| Article | Year |
|---|---|
A hypothesis on the role of the human immune system in covid-19.
Topics: Ageusia; Angiotensin-Converting Enzyme 2; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-1 | 2020 |
Lung defenses against infection: a clinical correlation.
Topics: Cilia; Complement System Proteins; Fibronectins; Filtration; Humans; Immunoglobulins; Lung; Lymphocy | 1983 |
9 other studies available for guaifenesin and Pneumonia, Viral
| Article | Year |
|---|---|
Predictive Value of Adenoviral Load for Bronchial Mucus Plugs Formation in Children with Adenovirus Pneumonia.
Topics: Adenoviridae; Bronchi; Child; Coinfection; Humans; L-Lactate Dehydrogenase; Mucus; Pneumonia, Viral; | 2022 |
The risk factors involved in airway mucus plug in children with ADV Pneumonia.
Topics: Child; Humans; Mucus; Pneumonia, Mycoplasma; Pneumonia, Viral; Retrospective Studies; Risk Factors | 2023 |
Protective potential of expectorants against COVID-19.
Topics: Air Microbiology; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug T | 2020 |
Effect of Environmental Conditions on SARS-CoV-2 Stability in Human Nasal Mucus and Sputum.
Topics: Betacoronavirus; Coronavirus Infections; COVID-19; Hot Temperature; Humans; Humidity; Mucus; Nasal C | 2020 |
SARS-CoV-2 viral load predicts COVID-19 mortality.
Topics: Aged; Betacoronavirus; Coronavirus Infections; COVID-19; Female; Humans; Male; Middle Aged; Mucus; N | 2020 |
Soft matter science and the COVID-19 pandemic.
Topics: Betacoronavirus; Coronavirus Infections; COVID-19; Disinfection; Humans; Mucus; Nanoparticles; Pande | 2020 |
Protective potential of expectorants against COVID-19.
Topics: Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Dioxolanes | 2020 |
Estimated incidence of influenza-virus-associated severe pneumonia in children in El Salvador, 2008-2010.
Topics: Child, Preschool; El Salvador; Female; Humans; Incidence; Infant; Influenza A Virus, H1N1 Subtype; I | 2012 |
Human metapneumovirus infection induces long-term pulmonary inflammation associated with airway obstruction and hyperresponsiveness in mice.
Topics: Animals; Disease Models, Animal; Histocytochemistry; Lung; Lung Diseases, Obstructive; Metapneumovir | 2006 |